C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/02 (2006.01) A61K 31/18 (2006.01) A61K 31/4468 (2006.01) A61K 31/4545 (2006.01) A61K 31/7105 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2597341
The use of an HERG channel inhibitor for controlling the proliferation of cancer cells. Examples of such HERG channel inhibitors include dofetilide, cisapride, E-4031 and a siRNA molecule targeting a sequence involved in the expression of an HERG channel. Other ERG channels are also targets for these inhibitors.
L'invention concerne l'utilisation d'un inhibiteur de canal HERG pour réguler la prolifération de cellules cancéreuses. Des exemples de ces inhibiteurs de canal HERG comprennent le dofétilide, le cisapride, E-4031 et une molécule de siRNA ciblant une séquence impliquée dans l'expression d'un canal HERG. D'autres canaux HERG sont également des cibles pour ces inhibiteurs.
Wang Zhiguo
Yang Baofeng
Institut de Cardiologie de Montreal
Tessier Louis
LandOfFree
Depression of herg k+ channel function in mammalian cells... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Depression of herg k+ channel function in mammalian cells..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Depression of herg k+ channel function in mammalian cells... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1844291